Limitless Cartilage Bioregulator (Sigumir)
$59.99
Description
Amount Per Capsule
Sigumir® bioregulator complex A-4 (bovine cartilage amino acid) – 10mg*
*Daily Value not established
Other ingredients
Microcrystalline Cellulose, Gelatin and Calcium Stearate
The protein complex in this product is derived from organ meats sourced from EU-reared beef cattle.
Sigumir Cartilage Peptide Bioregulator
Sigumir A-4 cartilage peptide bioregulator is a natural peptide complex derived from the cartilage and bone tissues of young animals. It has been researched for its effects on the musculoskeletal system, particularly in supporting joint and bone health. Sigumir works by normalizing the metabolism and functions of cartilage and bone tissues, promoting protein synthesis, and addressing peptide deficiencies. Sigumir’s bioactive peptides are known for their ability to rejuvenate joint tissues and improve overall joint flexibility and comfort.
Sigumir Research
Sigumir peptide complex A-4 is a peptide bioregulator derived from cartilaginous tissues of young animals. Research into Sigumir focuses on its potential to support joint and spinal health, particularly in age-related degenerative conditions.
Cartilage Regeneration: Sigumir may stimulate chondrocyte proliferation and extracellular matrix synthesis. This could lead to improved cartilage repair and maintenance, potentially slowing the progression of osteoarthritis and other degenerative joint conditions.
Inflammation Modulation: The peptide complex in Sigumir may modulate inflammatory responses in joint tissues. By potentially reducing pro-inflammatory cytokine production, it could help mitigate chronic inflammation associated with various musculoskeletal disorders.
Bone Density Support: Sigumir may influence osteoblast activity and bone mineralization processes. This could contribute to maintaining or improving bone density, which is particularly relevant for conditions like osteoporosis.
Cellular Metabolism Regulation: The bioregulator may normalize metabolic processes in cartilaginous tissue cells. By potentially optimizing cellular energy utilization and protein synthesis, Sigumir could support overall joint tissue health and function.
Pain Management: Sigumir may indirectly affect pain perception in degenerative joint conditions. Through its potential anti-inflammatory and tissue-regenerative properties, it could contribute to reduced joint pain and improved mobility in affected individuals.
Product Focus
- Osteoarthritis
- Osteoporosis
- Osteochondrosis
- Temporomandibular joint diseases
